Trump backs negotiating drug prices under Medicare: White House
Tweet
Share
E-mail
FILE PHOTO: U.S. President-elect Donald Trump speaks at his election night rally in Manhattan, New York, U.S., November 9, 2016. REUTERS/Carlo Allegri/File Photo
WASHINGTON (Reuters) - President Donald Trump supports the government negotiating directly with drug companies on prices for drugs covered by the Medicare insurance program, the White House said on Tuesday.
"He's for it," White House spokesman Sean Spicer said, when asked at a briefing whether Trump still supports negotiating drug prices for the healthcare program.
Spicer said Trump was committed to using his "skills as a businessman" to drive prices down.
(Reporting by Emily Stephenson; Editing by James Dalgleish)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump meets with travel industry CEOs on push to boost foreign tourism
- OpenAI launches new Astra model amid growing scrutiny over agents' safety
- Volkswagen targets 9% operating margin by 2030
Create E-mail Alert Related Categories
ETFs, ReutersRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
